KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation (Q36025994)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation
scientific article

    Statements

    KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation (English)
    César Serrano
    Yuexiang Wang
    Adrián Mariño-Enríquez
    Jeffrey A Morgan
    Carol Beadling
    Christopher L Corless
    Jonathan A Fletcher
    31 March 2014
    e93-6

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit